A hair transplant moves follicles from the donor area to parts of the scalp affected by hair loss. It does not stop male pattern hair loss from continuing in the non-transplanted hair around them.
For some men with ongoing androgenetic alopecia, finasteride may help preserve that existing hair after surgery. It is not an automatic requirement for every transplant patient, and it should only be taken following an individual assessment and prescription.
Why finasteride may be discussed after a transplant
Finasteride reduces the conversion of testosterone to dihydrotestosterone (DHT), a hormone involved in the gradual miniaturisation of susceptible scalp follicles. The follicles normally selected from the donor area are more resistant to this process, but the native hair across the hairline, mid-scalp and crown may continue to thin.
This is why medication can form part of long-term planning even when the transplanted area has healed well. Its main purpose is to support susceptible, non-transplanted hair rather than to make newly placed grafts grow faster or to guarantee that a transplant will succeed.
Finasteride 1 mg is licensed in the UK for male pattern hair loss in men. The product information recommends one 1 mg tablet daily, but that is prescribing information rather than a recommendation for every reader. Suitability depends on the diagnosis, medical history, current medication, age, pattern of loss and the patient’s view of the possible benefits and risks.
What the transplant evidence actually shows
The most relevant direct study was a randomised, double-blind, placebo-controlled trial involving 79 men aged 20 to 45 with androgenetic alopecia. Participants took finasteride 1 mg or placebo from four weeks before their transplant until 48 weeks afterwards.
At week 48, the finasteride group had better photographic assessments and hair counts than the placebo group. Visible increases in hair across the superior and frontal scalp were recorded in 94% of participants taking finasteride and 67% of those taking placebo.
The distinction matters: this study assessed scalp hair surrounding the transplant. It did not report a 94% graft-survival rate, and its findings should not be presented that way.
Larger trials conducted in men with male pattern hair loss, outside the transplant setting, have also shown that finasteride 1 mg can slow progression and improve hair counts compared with placebo. These results support discussing treatment with men who still have susceptible native hair. They do not establish that every patient should start medication, or that the trial’s four-week pre-operative schedule must be followed in routine practice.
When should treatment start?
There is no single timetable that suits every transplant patient. The direct transplant trial began treatment four weeks before surgery, but that was a study protocol rather than a universal UK rule.
If you already take finasteride, do not make a routine change around the time of surgery without instructions from the clinician who prescribes it and your surgical team. The urgent MHRA advice about depression or suicidal thoughts, explained below, takes precedence.
If you are considering treatment for the first time, the discussion can take place before surgery or during follow-up. The prescriber should first confirm that the pattern is consistent with androgenetic alopecia. Sudden shedding, patchy loss, scalp inflammation or scarring may need a different assessment.
The UK product information says that three to six months of daily treatment may be needed before stabilisation can be expected. The British Association of Dermatologists notes that benefit may take longer to become apparent. Progress is therefore better assessed with consistent photographs over several months than by checking the mirror each day.
How long is finasteride taken?
Finasteride only maintains its effect while treatment continues. The product information states that, after treatment stops, the beneficial effects begin to reverse by around six months and return towards baseline by nine to twelve months.
That does not mean treatment must continue indefinitely regardless of circumstances. The decision should be reviewed over time, taking account of response, side effects, changes in health, fertility plans and personal preference. A review is also appropriate if there is no clear benefit after a reasonable treatment period.
Other side effects and precautions
Clinical trials and post-marketing monitoring have identified decreased libido, erectile dysfunction and ejaculation disorders. Depression is listed as an uncommon adverse effect in the current product information; the frequency of anxiety and suicidal thoughts cannot be estimated from the available post-marketing reports.
Other reported effects include breast tenderness or enlargement, testicular pain, changes in semen quality, allergic reactions and raised liver enzymes. Report a breast lump, pain or nipple discharge promptly. Swelling of the lips, tongue, throat or face, or difficulty breathing, requires urgent medical attention.
Finasteride can affect a prostate-specific antigen (PSA) blood-test result. Tell the clinician arranging or interpreting a PSA test that you take it. Men who are planning a family should also discuss the limited long-term fertility data with their prescriber.
Finasteride 1 mg is not indicated for women or anyone under 18. Women who are pregnant or may become pregnant must not handle crushed or broken tablets because of the potential risk to a male foetus. Whole tablets are coated for normal handling.
Do not take finasteride 1 mg while taking finasteride 5 mg, dutasteride or another 5-alpha-reductase inhibitor. Tell your prescriber and pharmacist about all medicines you use.
Who may be offered finasteride after surgery?
A man with ongoing miniaturisation and a substantial amount of native hair around the transplant may have more hair to preserve. Someone with a stable pattern, little susceptible hair in the recipient area, a contraindication or side effects may reach a different decision.
The Norwood Scale can describe the visible pattern, but it cannot decide whether medication is appropriate. A useful assessment also considers donor-area quality, scalp examination, progression shown in older photographs and relevant health history.
Finasteride is available only on prescription. The NHS advises that it is not supplied on the NHS for hair loss, so patients normally pay for a private prescription. Use a regulated prescriber and pharmacy, and avoid tablets obtained through unverified sellers.
Finasteride and other hair-loss treatments
Topical minoxidil is another licensed treatment for male pattern hair loss, although it works differently from finasteride. A clinician may discuss one treatment, both treatments or neither, depending on the patient. Do not begin applying minoxidil to a healing recipient area without the surgical team’s approval.
PRP and scalp micropigmentation are separate procedures and should not be described as substitutes for prescribed treatment. PRP evidence and protocols vary, while scalp micropigmentation changes the visual appearance of the scalp without treating follicle miniaturisation.
Medication review should be part of follow-up
A sensible review records whether the hair loss appears stable, whether side effects have occurred and whether continuing treatment still fits the patient’s priorities. Baseline and follow-up photographs taken with the same lighting, hair length and camera angle are more useful than day-to-day comparisons.
Patients should also continue to follow their own surgical instructions. The clinic’s hair transplant aftercare guide covers graft protection and early recovery, while the follow-up care guide explains longer-term reviews.
If you would like to discuss the available prescription pathways, visit the clinic’s hair-loss medication page. An online article cannot confirm a diagnosis or determine whether finasteride is suitable for you.
This article provides general information and is not a substitute for an individual medical assessment. Read the patient information leaflet supplied with your medicine and follow the advice of your prescriber.
